These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7238260)

  • 21. The clinical associations with hepatic steatosis: a retrospective study.
    Samarasinghe D; Tasman-Jones C
    N Z Med J; 1992 Feb; 105(928):57-8. PubMed ID: 1542474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo P; Keach JC; Batts KP; Lindor KD
    Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative studies of laparoscopy, histology and gray-scale echotomography in diffuse diseases of the liver.
    Vogel HM; Scherer K; Look D
    Endoscopy; 1980 Jul; 12(4):166-74. PubMed ID: 6447063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wierzbicka A; Socha P; Pronicki M; Skiba E; Werpachowska I; Kaczmarski M
    Acta Biochim Pol; 2011; 58(4):563-6. PubMed ID: 22140659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.
    Itoh S; Yougel T; Kawagoe K
    Am J Gastroenterol; 1987 Jul; 82(7):650-4. PubMed ID: 3605026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
    World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic steatohepatitis and cirrhosis with Mallory's hyalin with ultrastructural study of one case.
    Itoh S; Matsuo S; Ichinoe A; Yamaba Y; Miyazawa M
    Dig Dis Sci; 1982 Apr; 27(4):341-6. PubMed ID: 6175490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.
    Bosserhoff A; Hellerbrand C
    Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
    López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
    Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury.
    Van Waes L; Lieber CS
    Gastroenterology; 1977 Oct; 73(4 Pt 1):646-50. PubMed ID: 408218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The variation of pathological changes in the liver evaluated by double biopsies.
    Baunsgaard P; Sanchez GC; Lundborg CJ
    Acta Pathol Microbiol Scand A; 1979 Jan; 87(1):51-7. PubMed ID: 420006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nonalcoholic steatohepatitis. Three case reports].
    Eivindson MV; Hamilton-Dutoit S; Grønbaek H
    Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Accuracy of sonography in the diagnosis of diffuse liver parenchymal diseases--comparison of sonography and liver histology].
    Steinmaurer HJ; Jirak P; Walchshofer J; Clodi PH
    Ultraschall Med; 1984 Jun; 5(3):98-103. PubMed ID: 6474150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current trends in liver biopsy indications in chronic liver diseases].
    Cadranel JF; Nousbaum JB
    Presse Med; 2012 Nov; 41(11):1064-70. PubMed ID: 22425478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and laboratory findings in the patients with alcoholic steatosis and liver steatofibrosis].
    Knezević S; Kallai L; Gjurasin M
    Lijec Vjesn; 1968; 90(10):929-41. PubMed ID: 5195768
    [No Abstract]   [Full Text] [Related]  

  • 38. Alcoholic liver disease: clinical patterns and diagnosis.
    Sherlock S
    Acta Med Scand Suppl; 1985; 703():103-10. PubMed ID: 3867238
    [No Abstract]   [Full Text] [Related]  

  • 39. [Scintigraphic aspects of hepatic steatosis. Histologic and endoscopic correlations].
    Banciu T; Berinde L; Prodan P; Deutsch G; Tudose N; Berinde L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(1):57-64. PubMed ID: 37571
    [No Abstract]   [Full Text] [Related]  

  • 40. Ultrasound scanning in the detection of hepatic fibrosis and steatosis.
    Saverymuttu SH; Joseph AE; Maxwell JD
    Br Med J (Clin Res Ed); 1986 Jan; 292(6512):13-5. PubMed ID: 3080046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.